ACTIVA
Report
- Report Number
- 2182207-2022-00197
- Event Type
- Injury
- Date Received
- February 4, 2022
- Date of Event
- December 7, 2021
- Report Date
- February 4, 2022
- Manufacturer
- MEDTRONIC NEUROMODULATION
- Product Code
- MBX
- PMA / PMN Number
- P960009
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
DALIC LJ, WARREN AEL, BULLUSS KJ, ET AL. DBS OF THALAMIC CENTROMEDIAN NUCLEUS FOR LENNOX-GASTAUT SYNDROME (ESTEL TRIAL). ANN NEUROL. 2021.10.1002/ANA.26280. DEEP BRAIN STIMULATION (DBS) IS AN EMERGING TREATMENT FOR PATIENTS WITH LENNOX-GASTAUT SYNDROME (LGS), WITH INCREASING OFF-LABEL USE BASED ON SMALL, OPEN-LABEL STUDIES TARGETING THE CENTRO MEDIAN NUCLEUS OF THALAMUS. ELECTRICAL STIMULATION OF THE THALAMUS IN EPILEPSY OF THE LENNOX-GASTAUT PHENOTYPE) IS THE FIRST RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CM-DBS IN A CAREFULLY CHARACTERIZED COHORT OF YOUNG ADULTS WITH LGS. WE FOUND ALMOST 60% OF STIMULATED PARTICIPANTS HAD A =50% REDUCTION IN ELECTROGRAPHIC SEIZURES COMPARED WITH NONE OF THE CONTROLS, INDICATING A THERAPEUTIC EFFECT OF CM-DBS IN PATIENTS WITH LGS. REPORTED EVENTS 1 PATIENT EXPERIENCED A STAPH-AUREUS INFECTION AFTER AN EDEMA REQUIRING HARDWARE REMOVAL. 1 PARTICIPANT HAD A DROP SEIZURE LEADING TO FACIAL LACERATION, REQUIRING STITCHES UNDER SEDATION. 1 PATIENT EXPERIENCED A SUBDURAL HEMATOMA. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE REPORTED EVENT WITH ANY PREVIOUSLY REPORTED EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1316046 | ACTIVA | MBX | MEDTRONIC NEUROMODULATION | 37601 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Required Intervention |